@Genericbulletin profile picture
Generics bulletin @Genericbulletin

Up-to-date commercial intelligence about business opportunities in the #global #generic #medicines and #biosimilars markets

Joined September 2010
  • Tweets 5,164
  • Following 163
  • Followers 986
390 Photos and videos
Regulatory Recap: US Senate Passes Anti-Patent Thicket Bill, EU Council Debates Pharma Package bit.ly/3Lu3O9R
154
Entering The GGB Awards: One Week To Go! bit.ly/4faY0zS
130
J&J Confirms EU Stelara Biosimilars Are Imminent bit.ly/3Sd3xfe
117
Re-Elected Von Der Leyen Sets Out EU Commission Plans For Critical Medicines Act bit.ly/467Y8fp

Re-Elected Von Der Leyen Sets Out EU Commission Plans For Critical Medicines Act

As she was re-elected as president of the European Commission, Ursula von der Leyen set out plans for the next European Commission that include a Critical Medicines Act to secure the supply chain.

insights.citeline.com
87
Xbrane Inching Closer To Cimzia Biosimilar Trials With Batch Production bit.ly/3Y9t5Of
1
219
Hikma Launches First US Sodium Acetate With CGT Exclusivity bit.ly/4f57igG

Hikma Launches First US Sodium Acetate With CGT Exclusivity

Following on from a flurry of deal and launches, Hikma has released another product onto the US market with the first of its sodium acetate injections, bolstered by 180 days of Competitive Generic...

insights.citeline.com
55
Zydus’s ‘Transparency Failure’ Leads To Block On Indian Perjeta Biosimilar bit.ly/4eZYzMV
63
Hyloris Replaces Leadership After Continued Transaction Woes bit.ly/3y1d9TG
69
AI And Biosimilars: Untapped Area Full Of Potential – Or Hype? bit.ly/3LvgqgQ

AI And Biosimilars: Untapped Area Full Of Potential – Or Hype?

AI could help biosimilar developers with the development and manufacture of their products, but dependence on high-quality training datasets poses potential challenges.

insights.citeline.com
47
Biosimilars Report Bolsters IGBA’s Calls To Streamline Development Process bit.ly/4cHq77U
2
2
111
Generics Bulletin Explains: After Humira Biosimilars, Will It Be Groundhog Day For Stelara? bit.ly/3W74Ai8
60
UK Prices Continue To Shoot Up In June bit.ly/4f5Xzqg
37
Fresenius Follows US Denosumab Filing With EU Acceptance bit.ly/3LuNi9v
49
ANI Acquires Alimera Sciences To Bolster Ophthalmology Portfolio bit.ly/3VTrNUQ
34
PBMs Hinder Access To Generics And Biosimilars, Finds FTC’s Investigation bit.ly/4f2Zhci
40
Cipla’s Verma Succeeds Kabi US Veteran Ducker As CEO bit.ly/3LlkOiz
71
Apotex Secures Canadian License For Loqtorzi From Coherus bit.ly/4eRTWo5
1
126
AEON Aims For Biosimilar Pathway For Lead Candidate In Cervical Dystonia bit.ly/3LlksbE
53
South Africa Drops J&J Bedaquiline Scrutiny After Generic Market Opens Up bit.ly/3RYDGYv
48
Celltrion’s Xolair Biosimilar Reaches UK, Following Key US Filing bit.ly/4eQHTax
84
Load more